Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The paradoxical role of tumor-infiltrating immune cells in lung cancer
Xiaodan Zheng, Yongfeng Hu, Chengfang Yao
Intractable & Rare Diseases Research (2017) Vol. 6, Iss. 4, pp. 234-241
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer
Jie Sun, Zicheng Zhang, Siqi Bao, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000110-e000110
Open Access | Times Cited: 249
Molecular Signature of Subtypes of Non-Small-Cell Lung Cancer by Large-Scale Transcriptional Profiling: Identification of Key Modules and Genes by Weighted Gene Co-Expression Network Analysis (WGCNA)
Magdalena Niemira, François Collin, Anna Szałkowska, et al.
Cancers (2019) Vol. 12, Iss. 1, pp. 37-37
Open Access | Times Cited: 227
Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma
Shuguang Zuo, Min Wei, Shiqun Wang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 161
Multi-omics Data Analyses Construct TME and Identify the Immune-Related Prognosis Signatures in Human LUAD
Yuwei Zhang, Minglei Yang, Derry Minyao Ng, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 21, pp. 860-873
Open Access | Times Cited: 57
Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer
Mohamed Haider, Amr Elsherbeny, Valeria Pittalà, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1853-1853
Open Access | Times Cited: 26
Investigating the role of Kinesin family in lung adenocarcinoma via integrated bioinformatics approach
Gulnaz Tabassum, Prithvi Singh, Rishabh Gurung, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
NCAPD2 is a favorable predictor of prognostic and immunotherapeutic biomarker for multiple cancer types including lung cancer
Linyuan Feng, Yang Yang, Zhenhua Lin, et al.
Genes and Environment (2024) Vol. 46, Iss. 1
Open Access | Times Cited: 3
3D cell culture models in research: applications to lung cancer pharmacology
Nathan Vella, Anthony G. Fenech, Vanessa Petroni Magri
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer
Max Jung, Michael Rose, Ruth Knuechel, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study
Valentina Masciale, Giulia Grisendi, Federico Banchelli, et al.
Annals of Translational Medicine (2019) Vol. 7, Iss. 22, pp. 619-619
Open Access | Times Cited: 24
NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma
Cui Zhao, Jian Liu, Haomiao Zhou, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 20
The EMT-Related Genes GALNT3 and OAS1 are Associated with Immune Cell Infiltration and Poor Prognosis in Lung Adenocarcinoma
Dan Luo, Mengying Fang, Shao Le, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 10
Open Access | Times Cited: 7
FGL2 is positively correlated with enhanced antitumor responses mediated by T cells in lung adenocarcinoma
Kai Yuan, Yanyan Feng, Hesong Wang, et al.
PeerJ (2020) Vol. 8, pp. e8654-e8654
Open Access | Times Cited: 19
PLAU and GREM1 are prognostic biomarkers for predicting immune response in lung adenocarcinoma
Dongliao Fu, Zhigang Hu, Haodi Ma, et al.
Medicine (2024) Vol. 103, Iss. 5, pp. e37041-e37041
Open Access | Times Cited: 2
Thalidomide suppresses breast cancer tumor growth by inhibiting tumor-associated macrophage accumulation in breast tumor-bearing mice
Xin Wang, Yanwei Shen, Li MengLv, et al.
European Journal of Pharmaceutical Sciences (2020) Vol. 151, pp. 105302-105302
Closed Access | Times Cited: 13
Comprehensive pan-cancer analysis of 33 human cancers reveals immunotherapeutic value of focal adhesion tyrosine kinase
Yujing Shi, Mengyang Ju, Yumeng Zhang, et al.
Medicine (2024) Vol. 103, Iss. 12, pp. e37362-e37362
Open Access | Times Cited: 1
Investigation on Potential Correlation Between Small Nuclear Ribonucleoprotein Polypeptide A and Lung Cancer
Maoxi Yuan, Chunmei Yu, Xin Chen, et al.
Frontiers in Genetics (2021) Vol. 11
Open Access | Times Cited: 10
DIRAS2 Is a Prognostic Biomarker and Linked With Immune Infiltrates in Melanoma
Wenli Xue, H. Zhu, Hongye Liu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
Regulatory T Cells, as a Target in Anticancer Immunotherapy
Tomohiro Enokida, Hiroyoshi Nishikawa
Immunotherapy (2017) Vol. 9, Iss. 8, pp. 623-627
Closed Access | Times Cited: 9
Differential Expression of AP-2 Transcription Factors Family in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma—A Bioinformatics Study
Dagmara Szmajda‐Krygier, Adrian Krygier, Marta Żebrowska, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 667-667
Open Access | Times Cited: 3
Immunological role and clinical prognostic significance of P2RY6 in lung adenocarcinoma: a multi-omics studies and single-cell sequencing analysis
Hong Wu, Xuhui Dong
World Journal of Surgical Oncology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 3
A Study on Immune Cell Infiltration in Lung Adenocarcinoma
Hongwen Zhao, Bingqing Sun
Combinatorial Chemistry & High Throughput Screening (2022) Vol. 25, Iss. 12, pp. 2082-2088
Closed Access | Times Cited: 5
Analysis of prognostic model based on immunotherapy related genes in lung adenocarcinoma
Peng Zhang, Wenmiao Wang, Lei Liu, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 5
Autophagy-related tumor subtypes associated with significant gene expression profiles and immune cell infiltration signatures to reveal the prognosis of non-small cell lung cancer
Rong-Ai Wang, Meng-Yu Zhang, Yingxiao Jiang, et al.
Journal of Cancer (2023) Vol. 14, Iss. 8, pp. 1427-1442
Open Access | Times Cited: 2
[Research Status of Tumor-associated Fibroblasts Regulating Immune Cells].
Guang Mu, Wenhao Zhang, Jingjing Huang, et al.
PubMed (2022) Vol. 25, Iss. 3, pp. 207-213
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top